Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
11.75
Dollar change
+0.12
Percentage change
1.03
%
Index- P/E- EPS (ttm)-1.53 Insider Own34.90% Shs Outstand17.95M Perf Week-1.43%
Market Cap211.73M Forward P/E- EPS next Y-2.11 Insider Trans0.11% Shs Float11.73M Perf Month-0.59%
Income-27.43M PEG- EPS next Q-0.58 Inst Own12.80% Short Float12.31% Perf Quarter4.72%
Sales0.22M P/S962.43 EPS this Y-39.72% Inst Trans-4.84% Short Ratio18.48 Perf Half Y67.62%
Book/sh2.49 P/B4.71 EPS next Y9.57% ROA-37.45% Short Interest1.44M Perf Year74.33%
Cash/sh2.32 P/C5.06 EPS next 5Y- ROE-50.60% 52W Range5.87 - 14.74 Perf YTD4.35%
Dividend Est.- P/FCF- EPS past 5Y-83.05% ROI-57.71% 52W High-20.28% Beta1.99
Dividend TTM- Quick Ratio3.18 Sales past 5Y416.19% Gross Margin- 52W Low100.17% ATR (14)0.78
Dividend Ex-Date- Current Ratio3.18 EPS Y/Y TTM12.21% Oper. Margin-12055.36% RSI (14)48.42 Volatility6.98% 6.35%
Employees10 Debt/Eq0.29 Sales Y/Y TTM-49.09% Profit Margin-12246.88% Recom1.33 Target Price19.67
Option/ShortYes / Yes LT Debt/Eq0.06 EPS Q/Q-10.45% Payout- Rel Volume1.23 Prev Close11.63
Sales Surprise-41.86% EPS Surprise-403.87% Sales Q/Q-56.12% EarningsMar 28 AMC Avg Volume78.18K Price11.75
SMA20-0.87% SMA50-2.61% SMA20023.51% Trades Volume96,381 Change1.03%
Date Action Analyst Rating Change Price Target Change
Jun-01-23Initiated Robert W. Baird Outperform $16
May-24-22Downgrade B. Riley Securities Buy → Neutral $14 → $7
Jul-07-21Reiterated Maxim Group Buy $32 → $42
Apr-21-21Initiated B. Riley Securities Buy $29
Jan-22-21Reiterated Maxim Group Buy $16 → $32
Sep-01-20Initiated BTIG Research Buy $23
Jul-15-20Reiterated H.C. Wainwright Buy $7 → $20
Today 04:01PM
Mar-26-24 04:01PM
Mar-13-24 08:00AM
Mar-05-24 08:00AM
Feb-12-24 09:00AM
09:00AM Loading…
Feb-06-24 09:00AM
Jan-30-24 08:00AM
Jan-16-24 08:30AM
Jan-02-24 08:00AM
Dec-18-23 04:01PM
Nov-29-23 08:35AM
08:00AM
Nov-27-23 08:00AM
Nov-17-23 08:15AM
Nov-15-23 09:00AM
10:11AM Loading…
Nov-02-23 10:11AM
09:54AM
Nov-01-23 06:44PM
04:10PM
Oct-31-23 08:00AM
Oct-30-23 09:07AM
Oct-25-23 09:00AM
Oct-17-23 08:00AM
Oct-16-23 09:00AM
Sep-07-23 09:00AM
Sep-05-23 08:00AM
Aug-28-23 10:22AM
Aug-08-23 09:07AM
06:33AM
Aug-07-23 04:00PM
08:00AM Loading…
Aug-01-23 08:00AM
Jul-31-23 08:00AM
Jul-12-23 08:00AM
Jul-11-23 08:00AM
Jul-10-23 04:00PM
May-24-23 09:00AM
May-08-23 08:00AM
May-05-23 06:15AM
May-04-23 08:13AM
May-03-23 04:10PM
Apr-30-23 08:34AM
Apr-24-23 09:00AM
Apr-19-23 08:30AM
Apr-11-23 08:00AM
Apr-03-23 09:00AM
Mar-20-23 06:46AM
Mar-06-23 09:48AM
Mar-03-23 09:53AM
Mar-02-23 04:05PM
Feb-21-23 09:00AM
Feb-08-23 08:45AM
Jan-25-23 07:45AM
Dec-22-22 08:00AM
Dec-21-22 09:55AM
Dec-08-22 08:00AM
Dec-06-22 04:00PM
Nov-29-22 08:00AM
Nov-20-22 07:34AM
Nov-14-22 09:00AM
Nov-02-22 04:00PM
Oct-26-22 08:10AM
Oct-19-22 11:48AM
08:00AM
Oct-10-22 11:46AM
Sep-07-22 09:00AM
Aug-04-22 05:00AM
Aug-03-22 04:10PM
Jul-27-22 08:00AM
Jul-25-22 08:00AM
Jul-17-22 08:19AM
Jun-22-22 08:00AM
Jun-16-22 08:00AM
Jun-09-22 07:35AM
Jun-07-22 09:55AM
08:36AM
Jun-02-22 06:22AM
May-25-22 12:07PM
10:06AM
May-24-22 08:59AM
May-23-22 04:00PM
May-18-22 09:00AM
May-10-22 08:00AM
May-06-22 01:30PM
May-05-22 04:00PM
May-03-22 11:44AM
Apr-28-22 07:00AM
Apr-25-22 04:00PM
Apr-14-22 03:38PM
Apr-13-22 04:00PM
Apr-11-22 08:00AM
Apr-04-22 09:00AM
Mar-30-22 08:00AM
Mar-25-22 09:00AM
Mar-15-22 08:00AM
Mar-14-22 04:30PM
Mar-04-22 04:30AM
Mar-03-22 04:00PM
Feb-23-22 09:00AM
Feb-08-22 09:00AM
Feb-07-22 07:14AM
INmune Bio, Inc. Is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprograms the immune system to fight cancer and Alzheimer's disease. Its products include pipeline, INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate. The company was founded by Mark Lowdell in September 2015 and is headquartered in Boca Raton, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Juda ScottDirectorNov 10 '23Buy6.957,00048,65037,000Nov 13 11:31 AM
Schroeder Timothy jDirectorJul 12 '23Sale11.0110,000110,08582,187Jul 14 04:05 PM